What is it with India and diabetes trials gone wrong?
In two words, the answer, IMO, is protocol violations. Type-2 diabetes is a really, really big problem in India (#msg-13297601); the investigators must be under enormous pressure to bend the rules.
“The notion that there’s a Chinese Wall between sell-side analysts and investment bankers may be the second-biggest piece of BS ever promulgated in any area of human knowledge!”